CENTERPIECE BIO
Pioneering Serum-Free Technology for Regenerative Medicine
Introduction to Centerpiece Bio
Centerpiece Bio is at the forefront of the biotechnology sector, having developed Korea's first serum-free stem cell culture medium[cite: 33, 93]. Our primary goal is the localization of essential bio-materials to ensure high safety and stable supply for the global medical industry[cite: 33, 230].
- Developed chemically defined culture fluids to eliminate the risks of animal pathogens and immunological responses found in Fetal Bovine Serum (FBS)[cite: 43, 277, 279].
- Focusing on the rapidly growing regenerative medicine market with a specialized "Fast Track" approach for commercialization[cite: 231, 350].
Organizational Structure
Our organizational framework is designed to facilitate seamless collaboration between research, manufacturing, and clinical care.
Bio Tech
Focused on R&D, Quality Control (QC), and the production of specialized SC and NK cell media[cite: 66, 70, 73, 74].
Healthcare
Managing the medical application of cell therapies through global healthcare platforms and dedicated clinics[cite: 78, 846].
Cosmetics
Harnessing stem cell technology to create high-performance functional skincare and aesthetic solutions[cite: 55, 49].
Technology and Patents
Patent No. 10-2021-0008888
Innovation: Chemically defined stem cell culture fluid that overcomes the harmfulness of animal serum components[cite: 42, 43].
This technology ensures 0% failure rate in GMP-grade cultures and maintains superior cell differentiation properties[cite: 267, 306].
Global Strategy
Centerpiece Bio leverages automation and global partnerships to scale our technological advantages worldwide[cite: 93, 103].
- Smart Factory Platform: Establishing automated NK cell anti-cancer production lines through global bio smart factories[cite: 105].
- Supply Chain Localization: Reducing reliance on imported materials and mitigating risks from global trade volatility[cite: 220, 230].
- B2B & CMO: Providing OEM/ODM services and annual supply contracts for domestic and international bio-firms[cite: 38, 103].